Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 46 AL 60

Learning, retrieval, and recognition are compromised in aMCI and mild AD: are distinct episodic memory processes mediated by the same anatomical structures?

Balthazar ML, Yasuda CL, Cendes F, Damasceno BP.

J Int Neuropsychol Soc. 2010 Jan;16(1):205-9. doi: 10.1017/S1355617709990956. Epub 2009 Oct 19.

Searching for new animal models of Alzheimer's disease

Epis R, Gardoni F, Marcello E, Genazzani A, Canonico PL, Di Luca M.

Eur J Pharmacol. 2010 Jan 10;626(1):57-63. doi: 10.1016/j.ejphar.2009.10.020. Epub 2009 Oct 15.

Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?

Sierksma AS, van den Hove DL, Steinbusch HW, Prickaerts J.

Eur J Pharmacol. 2010 Jan 10;626(1):72-82. doi: 10.1016/j.ejphar.2009.10.021. Epub 2009 Oct 20.

Depression and Alzheimer's disease: neurobiological links and common pharmacological targets

Caraci F, Copani A, Nicoletti F, Drago F.

Eur J Pharmacol. 2010 Jan 10;626(1):64-71. doi: 10.1016/j.ejphar.2009.10.022. Epub 2009 Oct 18.

Alzheimer's disease and endothelial dysfunction

Bomboi G, Castello L, Cosentino F, Giubilei F, Orzi F, Volpe M.

Neurol Sci. 2010 Feb;31(1):1-8. doi: 10.1007/s10072-009-0151-6. Epub 2009 Oct 17.

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

Palop JJ, Mucke L.

Neuromolecular Med. 2010 Mar;12(1):48-55. doi: 10.1007/s12017-009-8097-7. Epub 2009 Oct 17.

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease

Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A.

Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20.

Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations

Klaver AC, Finke JM, Digambaranath J, Balasubramaniam M, Loeffler DA.

Int Immunopharmacol. 2010 Jan;10(1):115-9. doi: 10.1016/j.intimp.2009.10.005. Epub 2009 Oct 17.

Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology

Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G.

Biochim Biophys Acta. 2010 Jan;1802(1):2-10. doi: 10.1016/j.bbadis.2009.10.006. Epub 2009 Oct 21.

APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasks

Röskam S, Neff F, Schwarting R, Bacher M, Dodel R.

Neurosci Biobehav Rev. 2010 Mar;34(4):487-99. doi: 10.1016/j.neubiorev.2009.10.006. Epub 2009 Oct 24.

Neurogenesis and Alzheimer's disease: Biology and pathophysiology in mice and men

Marlatt MW, Lucassen PJ.

Curr Alzheimer Res. 2010 Mar;7(2):113-25. doi: 10.2174/156720510790691362.

Copper in the brain and Alzheimer's disease

Hung YH, Bush AI, Cherny RA.

J Biol Inorg Chem. 2010 Jan;15(1):61-76. doi: 10.1007/s00775-009-0600-y. Epub 2009 Oct 28.

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy

Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M.

Eur J Neurol. 2010 Mar;17(3):405-12. doi: 10.1111/j.1468-1331.2009.02816.x. Epub 2009 Oct 28.

Interpretation of neuropathological lesions: its limitations in medico-legal experts' reports

Piercecchi-Marti MD, De Paula AM, Gavaudan G, Bartoli C, Pelissier-Alicot AL, Leonetti G, Pellissier JF.

Forensic Sci Int. 2010 Jan 30;194(1-3):e1-3. doi: 10.1016/j.forsciint.2009.07.010. Epub 2009 Oct 29.

Alzheimer's disease and neuronal network activity

Gleichmann M, Mattson MP.

Neuromolecular Med. 2010 Mar;12(1):44-7. doi: 10.1007/s12017-009-8100-3. Epub 2009 Nov 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias